Isotechnika Pharma Inc.

Isotechnika Pharma Announces Agreement With U.S. National Institutes of Health to Evaluate NICAM Portfolio as Anti-Viral Agents

Isotechnika Terminates Existing Agreement With ILJIN

Isotechnika Announces Changes to Senior Management and Board of Directors

Isotechnika Enters Into Development and Commercialization License Agreement With Vifor Pharma